Step by Step

INTRODUCTION

ABIM MOC Activity ID

9/12/2017 - Medical Grand Rounds: Rheumatology Year in Review

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Recognize the potential role of MRI and ultrasound of predicting synovitis in different phases of pre-clinical rheumatoid arthritis.
  • Recognize the outcome of some of the high impact randomized clinical trials in the field of Rheumatology, published in 2016 ,and their potential impact on the field.
  • Identify the recently-approved Biosimilars to manage Rheumatoid arthritis and how biosimilars may impact prescription practices and drive cost-saving.

Suggested Additional Reading:

  1. Klareskog L et al. Lancet (2009)
  2. Mankia K et al. Arthritis Rheumatol (2016)
  3. Sparks JA et al. Arthritis Rheumatol (2016)
  4. Nam JL, et al. Ann Rheum Dis (2016)
  5. Van Steenbergen HW et al. Ann Rheum Dis (2016)

Authors:
Ghaith Noaiseh, MD — Assistant Professor of Medicine Division of Rheumatology and Clinical Immunology, UPMC
Dr. Noaiseh receives grant/research salary support from HGS, BMS, Medimmune, Astra Zeneca, Ablynx and Pfizer.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.